Bonfá E - Search Results

1

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA. Ugarte-Gil MF, et al. Among authors: bonfa e. Lupus. 2018 Apr;27(4):536-544. doi: 10.1177/0961203317728810. Epub 2017 Aug 31. Lupus. 2018. PMID: 28857715

2

[Systemic lupus erythematosus in the aged: clinical and laboratory characteristics].

Takayasu V, Bonfá E, Levy Neto M, Kumeda C, Daud RM, Cossermelli W. Takayasu V, et al. Among authors: bonfa e. Rev Hosp Clin Fac Med Sao Paulo. 1992 Jan-Feb;47(1):6-9. Rev Hosp Clin Fac Med Sao Paulo. 1992. PMID: 1307405 Portuguese.

3

Lipoprotein(a) levels in systemic lupus erythematosus.

Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhão RC. Borba EF, et al. Among authors: bonfa e. J Rheumatol. 1994 Feb;21(2):220-3. J Rheumatol. 1994. PMID: 8182628

4

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

Borba EF, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 1997;6(6):533-9. doi: 10.1177/096120339700600610. Lupus. 1997. PMID: 9256312

5

Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.

Pasoto SG, Mendonça BB, Bonfá E. Pasoto SG, et al. Among authors: bonfa e. Lupus. 2002;11(3):175-80. doi: 10.1191/0961203302lu163oa. Lupus. 2002. PMID: 11999882

6

Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.

Borba EF, Turrini-Filho JR, Kuruma KA, Bertola C, Pedalini ME, Lorenzi MC, Bonfá E. Borba EF, et al. Among authors: bonfa e. Lupus. 2004;13(4):223-7. doi: 10.1191/0961203304lu528oa. Lupus. 2004. PMID: 15176656

7

The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus.

Hayata AL, Borba EF, Bonfá E, Kochen JA, Goldenstein-Schainberg C. Hayata AL, et al. Among authors: bonfa e. Lupus. 2005;14(8):613-7. doi: 10.1191/0961203305lu2177oa. Lupus. 2005. PMID: 16175933

8

Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.

Fialho SC, Bonfá E, Vitule LF, D'Amico E, Caparbo V, Gualandro S, Pereira RM. Fialho SC, et al. Among authors: bonfa e. Lupus. 2007;16(4):239-44. doi: 10.1177/0961203307076771. Lupus. 2007. PMID: 17439929

9

Capillaroscopy is a dynamic process in mixed connective tissue disease.

de Holanda Mafaldo Diógenes A, Bonfá E, Fuller R, Correia Caleiro MT. de Holanda Mafaldo Diógenes A, et al. Among authors: bonfa e. Lupus. 2007;16(4):254-8. doi: 10.1177/0961203307076517. Lupus. 2007. PMID: 17439931 Clinical Trial.

10

Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.

Sachet JC, Borba EF, Bonfá E, Vinagre CG, Silva VM, Maranhão RC. Sachet JC, et al. Among authors: bonfa e. Lupus. 2007;16(4):273-8. doi: 10.1177/09612033070160040901. Lupus. 2007. PMID: 17439934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters